FDA to crack down on risky stem cell offerings

November 16, 2017 by Matthew Perrone
US health agency to crack down on risky stem cell offerings
In this Dec. 5, 2014 file photo, a doctor injects a patient with a solution he says is rich in adult stem cells, at his practice in Beverly Hills, Calif. On Thursday, Nov. 16, 2017, the Food and Drug Administration laid out a strategy for regulating cell-based medicine, amid an effort to police a burgeoning medical field that has received little oversight. (AP Photo/Raquel Maria Dillon)

U.S. health authorities announced plans Thursday to crack down on doctors pushing stem cell procedures that pose the gravest risks to patients amid an effort to police a burgeoning medical field that previously has received little oversight.

The Food and Drug Administration laid out a strategy for regulating cell-based medicine, including hundreds of private clinics that have opened across the nation in the last decade. Many of the businesses promote stem cell injections for dozens of diseases including arthritis, multiple sclerosis and even Alzheimer's. They can cost $5,000 to $50,000, but there's little research that such procedures are safe or effective.

Researchers for years have called for a crackdown. FDA officials said they will focus their enforcement efforts on "bad actors" who inject stem cell mixtures into the bloodstream, nervous system or eyes. Regulators say those procedures pose the biggest risk to patients.

"We're going to be prioritizing places where we see products—not just being promoted inappropriately—but putting patients at potential risk," FDA Commissioner Scott Gottlieb told reporters on a conference call.

Gottlieb said the agency plans to use discretion in overseeing lower-risk procedures such as injections for achy joints, adding that this approach would allow the agency to get the "most bang for our regulatory buck." He also said the agency needs to be "nimble and creative" in its regulation to encourage legitimate researchers in the field.

Stem cells have long been recognized for their ability to reproduce and regenerate tissue. And while emerging research suggests that they will eventually be used to treat a range of debilitating diseases, they are currently only approved for a handful of medical procedures. For instance, adult stem cells from bone marrow transplants have long been used to treat leukemia and other blood diseases.

Most of the new clinics offer adults stem cells isolated from fat. Practitioners collect the fluid from patients via liposuction, treat it with chemicals and then inject it back into the body to treat various conditions.

Three Florida women were left nearly or completely blind by one such fat-based procedure, according to a report published earlier this year in the New England Journal of Medicine. The Florida Medical board previously revoked the license of another stem cell practitioner after two patients died under his care after receiving IV drips of stem cells to the bloodstream.

In August the FDA took action against clinics in Florida and California. The agency issued a warning letter to Sunrise, Florida-based US Stem Cell Clinic for marketing unapproved procedures for heart disease, Parkinson's disease and other conditions. And U.S. marshals, under FDA instructions, seized vials of an unproven vaccine from StemImmune Inc. of San Diego.

The FDA's authority to regulate stem cell procedures is a murky area that has been debated for years.

Typically the agency does not regulate individual doctors or their in-office procedures, focusing instead on products developed by drug and medical device manufacturers. But FDA has asserted its authority in certain cases when doctors begin processing stem cells and marketing them to treat serious diseases.

Guidelines released by the agency Thursday aim to clarify how much processing cells can undergo before triggering FDA regulation.

Explore further: FDA cites 'Significant deviations' at florida stem cell clinic

Related Stories

FDA cites 'Significant deviations' at florida stem cell clinic

August 29, 2017
(HealthDay)—A Florida stem cell clinic has received a warning letter from the U.S. Food and Drug Administration about what the agency describes as serious problems that could pose health risks to patients.

Experts: Unproven stem cell procedures need more oversight

September 9, 2015
Federal officials need to do more to prevent for-profit stem cell clinics from exploiting and potentially injuring patients, according to an article published in a leading medical journal.

Finally, unproven stem cell clinic practices might be curtailed

October 27, 2017
In a welcomed move, the Therapeutic Goods Administration (TGA) has this week announced reforms will be introduced in 2018 to address long held concerns about the provision of unproven stem cell treatments to increasing numbers ...

Swiss authorities target 'live cell' injection clinics

March 26, 2015
Swiss health regulators announced Thursday they have launched a criminal probe into clinics suspected of giving clients potentially dangerous animal cell injections as part of anti-ageing treatments.

Medical tourism in spotlight as experts call for tighter regulation

July 5, 2017
Countries should unite to tackle unscrupulous advertising of unproven therapies involving stem cells, experts say.

Stem cell clinics and businesses are registering for-profit, pay-to-participate

July 19, 2017
The Future Science Group (FSG) journal Regenerative Medicine, today announces the publication of a new Perspective article, in which Leigh Turner (University of Minnesota, MN, USA) discusses the urgent need for careful screening ...

Recommended for you

Enzyme identified as possible novel drug target for sickle cell disease, Thalassemia

July 19, 2018
Medical researchers have identified a key signaling protein that regulates hemoglobin production in red blood cells, offering a possible target for a future innovative drug to treat sickle cell disease (SCD). Experiments ...

Mice given metabolite succinate found to lose weight by turning up the heat

July 19, 2018
A team of researchers with members from institutions across the U.S. and Canada has found that giving the metabolite succinate to mice fed a high-fat diet prevented obesity. In their paper published in the journal Nature, ...

Supplement may ease the pain of sickle cell disease

July 19, 2018
(HealthDay)—An FDA-approved supplement reduces episodes of severe pain in people with sickle cell disease, a new clinical trial shows.

Scientists uncover DNA 'shield' with crucial roles in normal cell division

July 18, 2018
Scientists have made a major discovery about how cells repair broken strands of DNA that could have huge implications for the treatment of cancer.

Researchers develop novel bioengineering technique for personalized bone grafts

July 18, 2018
Scientists from the New York Stem Cell Foundation (NYSCF) Research Institute have developed a new bone engineering technique called Segmental Additive Tissue Engineering (SATE). The technique, described in a paper published ...

Researchers report protein kinase as the switch controlling obesity and diabetes

July 18, 2018
One of the research lines targeting the worldwide obesity epidemic is the manipulation of brown adipose tissue, a 'good' type of fat that burns lipids to maintain an appropriate body temperature. Researchers at the Centro ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.